Robert J Hariri Celularity Inc (CELU) insider trading activity

Robert J Hariri is Chief Executive Officer of Celularity Inc. Currently has a direct ownership of 20,328 shares of CELU, which is worth approximately $37,606. The most recent transaction as insider was on Apr 13, 2025, when has been sold 1,154 shares (Class A Common Stock) at a price of $1.64 per share, resulting in proceeds of $1,892. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.3K

99.29% 3M change

99.29% 12M change

Total Value Held $37,606

Robert J Hariri Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 13 2025	SELL Payment of exercise price or tax liability	$1,892 $1.64 p/Share	1,154 Reduced 5.37%	20,328 Class A Common Stock
Apr 13 2025	BUY Exercise of conversion of derivative security	-	3,281 Added 13.25%	21,482 Class A Common Stock
Apr 13 2024	SELL Payment of exercise price or tax liability	$4,742 $4.11 p/Share	1,154 Reduced 0.04%	2,855,889 Class A Common Stock
Oct 05 2023	BUY Open market or private purchase	$1,497,213 $0.16 p/Share	9,357,585 Added 24.67%	28,570,434 Class A Common Stock
Sep 29 2023	BUY Open market or private purchase	$1,540,971 $0.17 p/Share	9,064,539 Added 32.06%	19,212,849 Class A Common Stock
Apr 13 2023	SELL Payment of exercise price or tax liability	$8,193 $0.71 p/Share	11,540 Reduced 0.11%	10,148,310 Class A Common Stock
Mar 27 2023	BUY Grant, award, or other acquisition	$1,730,428 $0.83 p/Share	2,084,854 Added 17.03%	10,159,850 Class A Common Stock
Nov 30 2022	BUY Open market or private purchase	$17,200 $1.72 p/Share	10,000 Added 0.12%	8,074,996 Class A Common Stock
Nov 29 2022	BUY Open market or private purchase	$68,400 $1.71 p/Share	40,000 Added 0.49%	8,064,996 Class A Common Stock
Nov 28 2022	BUY Open market or private purchase	$69,600 $1.74 p/Share	40,000 Added 0.5%	8,024,996 Class A Common Stock
Aug 24 2022	BUY Exercise of conversion of derivative security	$341,739 $2.87 p/Share	119,073 Added 1.47%	7,984,996 Class A Common Stock
Apr 13 2022	BUY Grant, award, or other acquisition	-	131,234 Added 1.64%	7,865,923 Class A Common Stock
Jul 16 2021	BUY Other acquisition or disposition	-	7,734,689 Added 50.0%	7,734,689 Class A Common Stock

Also insider at

CYRX

Cryoport, Inc. Industrials

Director

BIVI

BIOVIE INC. Healthcare

Director

RJH

Robert J Hariri

Chief Executive Officer

Brentwood, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CELU shares.

Notify only if

Value

Insider Trading

Get notified when an Celularity Inc insider buys or sells CELU shares.

Notify only if

Operation

Value

Type

News

Receive news related to Celularity Inc

Track Activities on CELU

Account